
Class action lawsuit filed against ADMA Biologics for misleading investors and undisclosed transactions
Schall, Brown & Schwartz LLP has announced a class action lawsuit against ADMA Biologics for alleged securities violations including false statements, undisclosed related party transactions, channel stuffing to inflate revenue, and poor internal cont...


